CVS Health Earnings Before Interest Taxes and Depreciation Amortization EBITDA Over Time

<div class='circular--portrait' style='background:#FF6600;color: #f7f7f7;font-size:4em;padding-top: 25px;;'>CH</div>
CVS -- USA Stock  

Fiscal Quarter End: 30th of June 2020  

With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets. Continue to CVS Health Performance and CVS Health Correlation.

Search Competitors Fundamentals Over Time Against Earnings Before Interest Taxes and Depreciation Amortization EB IT DA

 
Refresh
CVS Health Earnings Before Interest Taxes and Depreciation Amortization EBITDA are relatively stable at the moment as compared to the last year. CVS Health reported last year Earnings Before Interest Taxes and Depreciation Amortization EBITDA of 12.04 Billion. As of 05/30/2020, Price to Earnings Ratio is likely to grow to 19.43, while Earnings per Basic Share are likely to drop 4.74.

  CVS Health Quarterly Earnings Before Interest Taxes and Depreciation Amortization EBITDA

Specify up to 10 symbols:


Cross Equities Earnings Before Interest Taxes and Depreciation Amortization EBITDA Analysis

Compare CVS Health and related stocks such as Cigna, Centene, Triple S Management, Humana Inc, Molina Healthcare, Magellan Health, Anthem Inc, Benefytt, COMPREHENSIVE CARE CORP Earnings Before Interest Taxes and Depreciation Amortization EBITDA Over Time
Select Fundamental

20102011201220132014201520162017201820192020
2.2 B2.2 BB2.8 B3.9 B3.9 B3.9 B4.4 B4.8 B11.9 B10.5 B
192.8 M260.6 M135 M366 M591 M848 M1.7 B1.8 B2.2 B2.8 B3.2 B
7.8 B7.9 B8.6 B9.9 B10.2 B11.6 B12.2 B9.3 BB12 B14.8 B
106.6 M111.6 M101.3 M93.3 M100.1 M81.8 M32.8 M99 M(72.7 M)154.5 M85.7 M
B2.6 B2.4 B2.5 B2.8 B3.1 B2.2 B4.7 B2.8 B4.3 B3.6 B
90 M153.6 M115.8 M235 M326 M514 M488 M(316 M)1.2 B1.1 B1.2 B
213.7 M255.8 M251.6 M240.2 M221.6 M183.2 M263.8 M277 M211.2 M248.5 M123.9 M
8.4 BB5.1 B5.2 B5.8 B6.2 B6.2 B5.6 BB7.9 B7.3 B
4.6 M4.6 M4.6 M(2 M)2.1 M1.6 M3.1 M38.7 M28.5 M57.2 M60.3 M
(17.7 M)(11.3 M)(4.9 M)7.8 M136 K(2.2 M)(3.1 M)(4.4 M)6.3 M(1.7 M)(1.4 M)

CVS Health and related stocks such as Cigna, Centene, Triple S Management, Humana Inc, Molina Healthcare, Magellan Health, Anthem Inc, Benefytt, COMPREHENSIVE CARE CORP Earnings Before Interest Taxes and Depreciation Amortization EBITDA description

EBITDA is a non-GAAP accounting metric that is widely used when assessing the performance of companies; calculated by adding Depreciation Amortization and Accretion back to Earning Before Interest and Taxes EBIT.

My Equities

My Current Equities and Potential Positions

CVS - USA Stock
CVS Health
<div class='circular--portrait-small' style='font-weight: 700;background:#FF6600;color: #f7f7f7;font-size:1.1em;padding-top: 10px;;'>CH</div>
CVS Health Fama & French Retail
Retail
Fama & French Classification
RegionNorth America
ExchangeBATS Exchange
$65.57
Continue to CVS Health Performance and CVS Health Correlation. Please also try Commodity Channel Index module to use commodity channel index to analyze current equity momentum.
Macroaxis is not a registered investment advisor or broker/dealer. All investments, including stocks, funds, ETFs, or cryptocurrencies, are speculative and involve substantial risk of loss. We encourage our investors to invest carefully. Much of our information is derived directly from data published by companies or submitted to governmental agencies which we believe are reliable, but are without our independent verification. Therefore, we cannot assure you that the information is accurate or complete. We do not in any way warrant or guarantee the success of any action you take in reliance on our statements or recommendations. Also, note that past performance is not necessarily indicative of future results. All investments carry risk, and all investment decisions of an individual remain the responsibility of that individual. There is no guarantee that systems, indicators, or signals will result in profits or that they will not result in losses. All investors are advised to fully understand all risks associated with any investing they choose to do. Hypothetical or simulated performance is not indicative of future results. We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown because hypothetical or simulated performance is not necessarily indicative of future results. For more information please visit our terms and condition page